CINECA IRIS Institutional Research Information System

REIMONDO, Giuseppe Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.221
EU - Europa 4.777
AS - Asia 2.631
SA - Sud America 374
AF - Africa 103
OC - Oceania 93
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.984
CN - Cina 1.126
IT - Italia 1.107
DE - Germania 568
SE - Svezia 474
IE - Irlanda 449
UA - Ucraina 341
FR - Francia 322
SG - Singapore 264
JP - Giappone 249
GB - Regno Unito 248
FI - Finlandia 240
KR - Corea 210
PL - Polonia 198
TR - Turchia 172
BR - Brasile 163
ES - Italia 152
VN - Vietnam 147
CA - Canada 135
AT - Austria 126
IN - India 95
AU - Australia 89
RU - Federazione Russa 83
MX - Messico 81
AR - Argentina 77
ID - Indonesia 74
BE - Belgio 66
NL - Olanda 59
HK - Hong Kong 58
CO - Colombia 55
GR - Grecia 55
HU - Ungheria 44
CL - Cile 38
RO - Romania 38
CH - Svizzera 36
PT - Portogallo 34
IR - Iran 33
TW - Taiwan 31
DK - Danimarca 29
RS - Serbia 29
DZ - Algeria 27
CZ - Repubblica Ceca 24
TH - Thailandia 24
SN - Senegal 23
IL - Israele 22
IQ - Iraq 19
MY - Malesia 18
PH - Filippine 18
ZA - Sudafrica 18
PE - Perù 16
TN - Tunisia 14
PK - Pakistan 13
SA - Arabia Saudita 13
EC - Ecuador 11
SI - Slovenia 11
VE - Venezuela 9
BA - Bosnia-Erzegovina 8
EG - Egitto 8
EU - Europa 7
HR - Croazia 7
OM - Oman 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
NO - Norvegia 6
SY - Repubblica araba siriana 5
UY - Uruguay 5
BH - Bahrain 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BG - Bulgaria 3
CR - Costa Rica 3
MA - Marocco 3
MU - Mauritius 3
NI - Nicaragua 3
TZ - Tanzania 3
BY - Bielorussia 2
CU - Cuba 2
CY - Cipro 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
PA - Panama 2
QA - Qatar 2
SM - San Marino 2
AP - ???statistics.table.value.countryCode.AP??? 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
IM - Isola di Man 1
MC - Monaco 1
Totale 14.203
Salva come PNG Salva come JPEG
Città #
Chandler 800
Beijing 673
Dublin 437
Fairfield 378
Houston 344
Ashburn 286
Ann Arbor 229
Redwood City 203
Jacksonville 200
Singapore 200
Wilmington 187
Torino 180
Woodbridge 179
Nyköping 162
Seattle 158
Medford 141
Cambridge 139
Princeton 126
Villeurbanne 115
Warsaw 114
Dearborn 113
Vienna 108
Dong Ket 96
Milan 87
Pisa 87
Guangzhou 84
Turin 72
Jakarta 59
Rochester 59
Rome 50
Shanghai 50
Tokyo 50
New York 47
Boston 46
Istanbul 44
Toronto 44
Munich 43
Los Angeles 42
Buenos Aires 38
Fremont 38
Ankara 35
Boardman 31
Bogotá 31
Moscow 31
Chicago 30
Helsinki 30
Würzburg 30
Hangzhou 29
San Diego 29
Paris 28
Seoul 28
Brussels 25
Hefei 25
Budapest 24
Santa Clara 24
Santiago 24
Taipei 23
Okazaki 21
Düsseldorf 20
London 20
Athens 19
Lappeenranta 19
Nanjing 19
Norwalk 19
Lachine 18
Seongnam 18
Phoenix 17
São Paulo 17
Brisbane 16
Hong Kong 16
Madrid 16
Padova 16
Tehran 16
Lima 15
Osaka 15
Washington 15
Zurich 15
Brno 14
Mountain View 14
Portland 14
Sydney 14
Belgrade 13
Curitiba 13
Falls Church 13
Florence 13
Frankfurt am Main 13
Fukuoka 13
Silver Spring 13
Trieste 13
Uberlândia 13
Berlin 12
Chengdu 12
Naples 12
San Jose 12
Lund 11
Ottawa 11
Amsterdam 10
Changsha 10
Gliwice 10
Jinan 10
Totale 7.615
Salva come PNG Salva come JPEG
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 1.113
Autonomous hypercortisolism: definition and clinical implications 613
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 473
AME position statement on adrenal incidentaloma. 410
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 370
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 367
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population? 328
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 286
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 281
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 276
Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas 275
Surgical remission of Cushing's syndrome reduces cardiovascular risk. 252
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 248
Adjuvant mitotane treatment for adrenocortical carcinoma 241
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 232
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 225
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 215
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 189
Predictors of morbidity and mortality in acromegaly: an Italian survey. 181
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment. 170
Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis. 166
Comparison of Reverse Triage with National Early Warning Score, Sequential Organ Failure Assessment and Charlson Comorbidity Index to classify medical inpatients of an Italian II level hospital according to their resource's need. 161
Acromegaly is associated with increased cancer risk: a survey in Italy 161
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 155
Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma 149
Inpatient disposition in overcrowded hospitals: is it safe and effective to use reverse triage and readmission screening tools for appropriate discharge? An observational prospective study of an Italian II level hospital 143
Laboratory differentiation of Cushing's syndrome 141
May an adrenal incidentaloma change its nature? 138
Adrenal incidentaloma, a five year experience. 134
[Subclinical Cushing's syndrome in adrenal incidentalomas] 134
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood 132
Insights on the natural history of adrenal incidentalomas 132
Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas 122
Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis? 116
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 115
Adrenocortical Carcinoma with Hypercortisolism. 112
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 111
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study 110
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 107
Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. 105
Evaluation of cardiovascular risk factors in patients with incidentally discovered adrenal adenoma during a follow-up longer than five years 104
Adjuvant mitotane treatment: a prospective experience at the San luigi Hospital, University of Turin, Italy, USA, 2008 103
Acute Primary Adrenal Insufficiency after Hip Replacement in a Patient with Acute Intermittent Porphyria. 101
Cyclic Cushing's syndrome due to ectopic ACTH secretion by an adrenal pheochromocytoma. 100
Valutazione prospettica di pazienti operati radicalmente per carcinoma corticosurrenalico in trattamento con mitotane adiuvante: correlazioni tra indici di massa corporea, livelli di mitotanemia ed efficacia. 99
Subclinical Cushing's syndrome 96
A prospective study on adjuvant mitotane 96
Sindrome di Cushing: l’esperienza dell’Ospedale San Luigi di Orbassano 93
Early introduction of simulation in the medical curriculum: the MedInTo perspective 89
Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis. 89
Epidemiology of acromegaly in Italy 89
Sindrome di cushing: esperienza dell'ospedale San Luigi di Orbassano in una serie consecutiva di 117 pazienti 88
The San Luigi hospital experience with adjuvant mitotane treatment in patients with adrenocortical cancer following radical resection 87
Adrenal pseudocyst mimicking cancer: a case report 86
Adrenal incidentaloma: a new cause of the metabolic syndrome? 85
Desmopressin test in mild Cushing syndrome. 84
Evaluation of Cardiovascular Risk Factors in Patients with Incidentally Discovered Adrenal Adenoma during a Follow-Up Longer Than Five Years. 82
Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System 81
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 81
Autocrine down-regulation of glucocorticoid receptors by interleukin-11 in human osteoblast-like cell lines. 80
Cardiovascular risk factors in patients with Cushing’s syndrome: data from a long term follow up after treatment 80
Circadian profile of serum melatonin in patients with Cushing's syndrome or acromegaly. 78
Is Follow-up of Adrenal Incidentalomas Always Mandatory? 77
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 76
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. 73
Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome 72
L'esperienza dell'ospedale san Luigi nel trattamento con mitotane adiuvante in pazienti operati radicalmente per carcinoma corticosurrenalico. 72
Hyperhomocysteinemia in patients with Cushing's syndrome 72
The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome 71
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. 70
Comparison of 1-mg versus 8-mg dexamethasone suppression test (DST) in patients with clinically inapparent adrenal adenoma 68
Emerging drugs for adrenocortical carcinoma 67
Demographic Data, Co-Morbidities, Malignancies and Mortality from the First Large-Scale Italian Study on Acromegaly. 66
Management of adrenal incidentalomas 65
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 64
Midnight salivary cortisol for diagnosis of subclinical Cushing’s syndrome in patients with clinically inapparent adrenocortical adenoma. 63
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study 63
Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome 62
Secondary hypoadrenalism 62
Sindrome di Cushing: l'esperienza dell'ospedale San Luigi in una serie consecutiva di 117 pazienti 60
The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. 56
Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy 56
Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus 56
Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy 56
Long-term follow-up in adrenal incidentalomas: an Italian Multicentre Study 55
Rapporto tra acromegalia e neoplasia: fantasia o realtà? 54
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 54
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 54
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 54
Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. 52
May an altered hypothalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism? 49
Prolonged adrenal insufficiency after the discontinuation of mitotane therapy 49
The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome 48
Risk of cardiovascular events in adrenal incidentalomas: an Italian long-term follow-up study 48
Cushing syndrome due to ectopic adrenocorticotropic hormone secretion in a3-year-old child. 48
Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. 47
The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. 46
Reversibility of Acute Adrenal Insufficiency after hip Replacement: A Case Series 46
The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome. 45
Limited role of hair cortisol and cortisone measurement for detecting cortisol autonomy in patients with adrenal incidentalomas 44
Totale 13.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.252
article - articoli 0
book - libri 0
conference - conferenze 5.784
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.724 0 0 106 195 124 247 230 205 237 150 125 105
2020/20211.822 137 91 154 94 139 89 173 148 149 199 144 305
2021/20222.274 133 111 131 209 188 115 174 143 120 175 389 386
2022/20232.828 269 236 108 237 243 565 187 204 334 120 187 138
2023/20242.069 220 249 125 162 179 198 195 180 50 137 193 181
2024/2025550 152 217 181 0 0 0 0 0 0 0 0 0
Totale 14.679